Sana Biotechnology, Inc. — Director's Dealing 2021

Feb 4, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Sana Biotechnology, Inc. (SANA)
CIK: 0001770121
Period of Report: 2021-02-03

Reporting Person: Wilderotter Mary Agnes (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$2.40	2030-05-09	Common Stock (93750)		Direct

Footnotes

F1: The option vests and becomes exercisable as to 25% of the underlying shares on May 10, 2021 and in 36 equal monthly installments thereafter.